Neuroprotective properties of melatonin in a model of birth asphyxia in the spiny mouse (Acomys cahirinus)

Dev Neurosci. 2009;31(5):437-51. doi: 10.1159/000232562. Epub 2009 Aug 14.

Abstract

Birth asphyxia is associated with disturbed development of the neonatal brain. In this study, we determined if low-dose melatonin (0.1 mg/kg/day), administered to the mother over 7 days at the end of pregnancy, could protect against the effects of birth asphyxia in a precocial species - the spiny mouse (Acomys cahirinus). At 37 days of gestation (term is 38-39 days), pups were subjected to birth asphyxia (7.5 min uterine ischemia) and compared to Cesarean section-delivered controls. At 24 h of age, birth asphyxia had increased markers of CNS inflammation (microglia, macrophage infiltration) and apoptosis (activated caspase-3, fractin) in cortical gray matter, which were reduced to control levels by prior maternal melatonin treatment. Melatonin may be an effective prophylactic agent for use in late pregnancy to protect against hypoxic-ischemic brain injury at birth.

MeSH terms

  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Apoptosis
  • Caspase 3 / metabolism
  • Cell Count
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / pathology*
  • Cytoprotection*
  • Female
  • Hypoxia-Ischemia, Brain / drug therapy*
  • Hypoxia-Ischemia, Brain / pathology
  • Immunohistochemistry
  • Infusion Pumps, Implantable
  • Macrophage Activation
  • Melatonin / administration & dosage*
  • Melatonin / blood
  • Melatonin / therapeutic use*
  • Microglia / metabolism
  • Murinae
  • Neurons / metabolism
  • Neurons / pathology
  • Oligodendroglia / metabolism
  • Oligodendroglia / pathology
  • Pregnancy
  • Prenatal Exposure Delayed Effects / metabolism
  • Radioimmunoassay
  • Staining and Labeling

Substances

  • Caspase 3
  • Melatonin